SCLN Financial Facts

General and administrative: 7.9M
Provision for income tax: 1.06M
See Full Income Statement

Total assets: 233.36M
Accounts receivable: 37.75M
See Full Balance Sheet

SciClone Pharmaceuticals, Inc. (SCLN) Earnings

  |   Expand Research on SCLN
Next EPS Date 3/10/17 *Est. EPS Growth Rate +4.3% *Last Qtr.
Average EPS % Beat Rate +197.9% Revenue Growth Rate -5.6% *Last Qtr.
Average % Move 1-Wk after EPS +8.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/9/16 Q316 $0.24N/A N/A $40.5M$42.9M N/A Details
8/9/16 Q216 $0.20N/A N/A $39M$37.9M N/A Details
5/10/16 Q116 $0.19N/A N/A $36.5M$33.6M N/A Details
3/10/16 Q415 $0.30N/A N/A $42.9M$41.1M N/A Details
11/9/15 Q315 $0.23N/A N/A $42.9M$34.3M N/A Details
8/10/15 Q215 $0.26$0.12 +$0.14$37.9M$37.27M N/A Details
5/11/15 Q115 $0.19$0.03 +$0.16$33.6M$34M N/A Details
11/10/14 Q314 $0.17$0.12 +$0.05$34.3M$34.9M Details